MONTREAL, June 30 /CNW Telbec/ - Noveko International Inc. ("the
Company") announces that some preconditions to the transaction for the sale of
the shares of Bolduc Leroux Inc. ("BLI") held by the Corporation having not
yet been fulfilled, the parties have agreed to postpone the closing of the
transaction to no later than July 7, 2009.
Noveko International Inc. offers innovative solutions worldwide in the
biomedical and environmental fields. The Company, through its subsidiaries,
specializes in the following business segments: the development and marketing
of products derived from its patented antimicrobial filtration technology,
primarily air filters, surgical masks and respirators, as well as other
antimicrobial products such as AZURO(TM) disinfectants and - the development,
manufacturing, and marketing of portable real-time ultrasound scanners for use
in human and veterinary medicine.
For further information:
For further information: Chantal Vennat, Director, Investor Relations
and Corporate Communications, Noveko International Inc., (514) 875-0606,